Research in the Neuro-Oncology department focuses on extending our understanding of the genetic abnormalities and molecular events responsible for the development, progression and spread of brain tumors. By translating laboratory findings into new treatments, we can offer more effective therapies and improve survival rates and quality of life for brain tumor patients.
We employ researchers recognized for their expertise in the areas implicated in the development and progression of central nervous system tumors. These researchers work closely with physician-scientists to integrate laboratory discoveries and clinical observations into treatment innovations.
In addition, our researchers participate in multi-institutional research efforts, collaborating with world-renowned brain tumor treatment programs such as the Collaborative Ependymoma Research Network (CERN) Foundation and the Brain Tumor Trials Collaborative (BTTC).